First Light Asset Management LLC Buys Shares of 6,431,799 Senseonics Holdings, Inc. (NYSE:SENS)

First Light Asset Management LLC purchased a new position in shares of Senseonics Holdings, Inc. (NYSE:SENS - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 6,431,799 shares of the company's stock, valued at approximately $3,366,000. First Light Asset Management LLC owned 1.08% of Senseonics as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently modified their holdings of the company. Renaissance Technologies LLC bought a new stake in Senseonics during the fourth quarter worth approximately $720,000. Geode Capital Management LLC increased its position in shares of Senseonics by 9.7% during the 4th quarter. Geode Capital Management LLC now owns 6,405,100 shares of the company's stock valued at $3,354,000 after purchasing an additional 566,704 shares during the period. XTX Topco Ltd bought a new stake in shares of Senseonics in the 4th quarter worth $179,000. Virtu Financial LLC acquired a new stake in shares of Senseonics in the fourth quarter valued at $148,000. Finally, Charles Schwab Investment Management Inc. boosted its stake in Senseonics by 9.0% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 3,339,698 shares of the company's stock valued at $1,748,000 after buying an additional 274,842 shares in the last quarter. Institutional investors own 12.36% of the company's stock.

Senseonics Trading Down 1.8 %

NYSE SENS traded down $0.01 on Friday, hitting $0.71. 4,243,242 shares of the company were exchanged, compared to its average volume of 6,322,147. Senseonics Holdings, Inc. has a twelve month low of $0.25 and a twelve month high of $1.40. The company's 50 day moving average price is $0.67 and its 200-day moving average price is $0.62. The firm has a market capitalization of $464.49 million, a P/E ratio of -5.46 and a beta of 0.84. The company has a debt-to-equity ratio of 59.17, a current ratio of 2.47 and a quick ratio of 2.38.

Senseonics (NYSE:SENS - Get Free Report) last issued its quarterly earnings results on Monday, March 3rd. The company reported ($0.12) EPS for the quarter, missing the consensus estimate of ($0.03) by ($0.09). Senseonics had a negative net margin of 362.30% and a negative return on equity of 842.25%. During the same quarter in the previous year, the company posted ($0.07) earnings per share. Analysts predict that Senseonics Holdings, Inc. will post -0.14 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

SENS has been the subject of a number of research analyst reports. Mizuho initiated coverage on shares of Senseonics in a report on Thursday, April 10th. They issued an "outperform" rating and a $2.00 price target for the company. HC Wainwright restated a "buy" rating and set a $2.00 target price on shares of Senseonics in a report on Wednesday, March 5th.

Senseonics Company Profile

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.